Project Grant HT9425261E025
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $628K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $621,779 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2029. The award supports research on "Modulating Immune Stress Pathways as a Strategy for CIPN Prevention and Cancer Management," focused on developing strategies to prevent chemotherapy-induced peripheral neuropathy (CIPN) while...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $810,171 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, with a completion date of August 31, 2028. The award supports research investigating the therapeutic effects of peroxisome proliferator-activated receptor alpha (PPAR-α) agonists on combat-induced proliferative vitreoretinopathy, a serious...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.80M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025, through September 30, 2028. The award supports research on PEDF-enriched exosomes for improving urethral sphincter function after radical prostatectomy. This three-year initiative addresses a critical post-surgical complication affecting military service members...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $2.47 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a completion date of September 29, 2029. The project, titled "Allograft vs. Autograft to Improve Timely Return to Duty Following Nonunion," supports advanced biomedical research addressing critical health challenges relevant to...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $1.48M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 30, 2025, with a completion date of September 29, 2029. The award supports the Intraosseous Antibiotics for Osseointegration (IOAOI) research initiative, which investigates advanced biomedical solutions for military-relevant orthopedic injuries. This project...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $2.2M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded November 1, 2025, with a completion date of October 31, 2029. The award supports the SEXTANT Study, which evaluates a new protocolized antibiotic care strategy for severe open fractures compared to standard-of-care antibiotic protocols. The research employs a hierarchical...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- Federal Project Grant Award Summary Award: The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded Duke University's Office of Research Administration a Project Grant of $564,705 on September 15, 2025, for research extending through September 14, 2028. The award supports the identification of oncofusion-interacting proteins as essential drug targets for common and rare oncofusions in rhabdomyosarcoma. This research initiative aligns...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $960,626 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a performance period through July 31, 2027. The award supports research into NUAK2 as a novel splicing regulatory kinase in neuroendocrine prostate cancer. This project contributes to the DHA's mission to transform healthcare for service members and...
- This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...